The Clinical and Regulatory Affairs team at Wugen is responsible for ensuring the safe and effective development of innovative immuno-oncology therapies. This team oversees clinical trial management, regulatory compliance, and pharmacovigilance, coordinating efforts to navigate the complexities of clinical development and regulatory submissions. By collaborating with various stakeholders, they ensure that the company meets all regulatory standards while advancing its promising cell therapy programs.